T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Clinical trial NCT03190967 · TERMINATED
Trial details
- NCT number
- NCT03190967
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2021-06-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.